Page last updated: 2024-11-02

pifithrin and Myocardial Ischemia

pifithrin has been researched along with Myocardial Ischemia in 2 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mocanu, MM1
Yellon, DM1
Liu, P1
Xu, B1
Cavalieri, TA1
Hock, CE1

Other Studies

2 other studies available for pifithrin and Myocardial Ischemia

ArticleYear
p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning.
    FEBS letters, 2003, Dec-04, Volume: 555, Issue:2

    Topics: Androstadienes; Animals; Benzothiazoles; Blotting, Northern; Down-Regulation; Enzyme Inhibitors; Isc

2003
Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:6

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; DNA Fragmentation; Electrocardiograp

2006